Immunology and Immunotherapy in Critical Care: An Overview
Overview
Nursing
Authors
Affiliations
Until recently, immunology was not a major focus of attention in the acute and critical care setting. With the evolution of immunotherapy, however-including the development of monoclonal antibodies, checkpoint inhibitors, and adoptive cellular therapies-an in-depth understanding of the immune system has become necessary to properly care for acutely ill patients. Lymphocytes (ie, T cells and B cells) play a major role in the daily functioning of the immune response. The interaction of these cells in protecting the body against infection and foreign substances is complicated and is the basis for many of the innovations in immunology and cancer treatment. This article explores basic immunology concepts, new drug categories, and adoptive cellular therapies that are at the forefront of cancer therapy.
Zhu R, Cao L, Wu T, Zhang Z, Han M, Liu H Transl Pediatr. 2024; 13(7):1169-1178.
PMID: 39144435 PMC: 11320001. DOI: 10.21037/tp-24-95.
SETDB1 as a cancer target: challenges and perspectives in drug design.
Hassanie H, Penteado A, de Almeida L, Calil R, da Silva Emery F, Costa-Lotufo L RSC Med Chem. 2024; 15(5):1424-1451.
PMID: 38799223 PMC: 11113007. DOI: 10.1039/d3md00366c.
Insights into the Tumor Microenvironment-Components, Functions and Therapeutics.
Baghy K, Ladanyi A, Reszegi A, Kovalszky I Int J Mol Sci. 2023; 24(24).
PMID: 38139365 PMC: 10743805. DOI: 10.3390/ijms242417536.
Murine cancer cachexia models replicate elevated catabolic pembrolizumab clearance in humans.
Castillo A, Vu T, Liva S, Chen M, Xie Z, Thomas J JCSM Rapid Commun. 2021; 4(2):232-244.
PMID: 34514376 PMC: 8420755. DOI: 10.1002/rco2.32.
Nanomedicine to modulate immunotherapy in cutaneous melanoma (Review).
Volovat S, Negru S, Stolniceanu C, Volovat C, Lungulescu C, Scripcariu D Exp Ther Med. 2021; 21(5):535.
PMID: 33815608 PMC: 8014970. DOI: 10.3892/etm.2021.9967.